Can a Child Get Multiple Osteochondromas If Parents Don't?

Yes. It is completely possible for a child to develop multiple osteochondromas (also known as hereditary multiple exostoses, or HME) even if neither parent has the condition or any history of the disease. In fact, while general estimates vary, research indicates that spontaneous mutations account for about 29% of all new multiple osteochondromas cases ^[1][2][3]. This occurs due to a spontaneous genetic change—often called a de novo mutation (a genetic alteration that is present for the first time in one family member).

While the genetic change happens at conception, the benign bone tumors (osteochondromas) themselves typically do not become visible until the child is a few years old.

Understanding Spontaneous (De Novo) Mutations

Multiple osteochondromas are usually caused by a change (mutation) in one of two specific genes: EXT1 or EXT2 ^[4][1][5]. These genes provide instructions for producing proteins that are essential for normal bone development ^[6]. In most families dealing with HME, a child inherits the changed gene from a parent who also has the condition ^[7].

However, in a de novo mutation, the genetic change happens randomly during conception—either in the sperm, the egg, or shortly after the embryo begins to form ^[7][8].

• Neither parent is at fault: There is nothing either parent did before or during pregnancy to cause this genetic change. It is a completely random event of nature.
• Parents do not carry the mutation: If tested, the parents’ DNA will typically show completely normal EXT1 and EXT2 genes ^[4][1].

Because the condition is highly penetrant—meaning almost everyone who has the gene mutation will eventually develop benign bone tumors—parents who truly do not have any signs of the condition are very unlikely to be silent carriers ^[9]. However, doctors may still recommend that parents get a physical exam or basic X-rays just to be absolutely certain they don’t have very small, unnoticeable osteochondromas ^[10][11].

The Role of Genetic Testing

Doctors primarily diagnose multiple osteochondromas visually and through X-rays. However, genetic testing (usually done via a simple blood draw or cheek swab) can look for the specific mutation to confirm the diagnosis ^[12].

Finding out whether the child has an EXT1 or EXT2 mutation can provide helpful clues for their medical care. Research shows that patients with an EXT1 mutation often have a more severe form of the condition, with a higher number of tumors and greater risk for limb deformities, compared to those with an EXT2 mutation ^[13][14]. Knowing which gene is involved helps the medical team know how closely they should monitor the child’s bone growth.

It is also important to note that in some cases, a genetic test might not find any mutation even though the child clearly has multiple osteochondromas on their X-rays ^[12][1]. A negative genetic test does not rule out the diagnosis.

What Does This Mean for the Future?

When a child develops multiple osteochondromas through a spontaneous mutation, it means their own genetic code now carries the changed EXT1 or EXT2 gene ^[4][5].

While the parents’ chance of having another child with HME is very low (since it was an isolated, random event), the affected child’s risk is different. Because HME is an autosomal dominant condition (meaning only one copy of the changed gene is needed to cause the disorder), the child will have a 50% chance of passing the genetic mutation on to each of their own future children ^[9]. Speaking with a genetic counselor can be a helpful step to understand these risks and discuss family planning.

Key Takeaways

• It is not your fault: Spontaneous mutations happen entirely by chance.
• The condition is hereditary going forward: While you are very unlikely to have another child with the condition, your diagnosed child will have a 50% chance of passing it to their future children ^[9].
• Testing provides clues, but isn’t perfect: Genetic testing can identify if the EXT1 or EXT2 gene is involved, which helps doctors predict how severe the condition might be ^[13][14]. However, X-rays remain the primary way to diagnose and monitor the benign bone tumors.